Cornerstone Pharmaceuticals, Inc. Initiates Phase I Clinical Trial Of CPI-613 For The Treatment Of Metastatic Colorectal Cancer 1/12/2015

Press/Media: Press / Media

PeriodJan 12 2015

Media coverage

1

Media coverage

  • TitleCornerstone Pharmaceuticals, Inc. Initiates Phase I Clinical Trial Of CPI-613 For The Treatment Of Metastatic Colorectal Cancer 1/12/2015
    Media name/outletClinicSpace
    CountryCanada
    Date1/12/15
    PersonsAngela Alistar